Tasigna receives FDA approval - hope to chronic myeloid leukemia

Armen Hareyan's picture
Advertisement

Cancer Drug Approval

Tasigna produced responses in 40% of patients with Philadelphia chromosome-positive chronic myeloid leukemia resistant or intolerant to prior cancer treatment.

Advertisement